Coronavirus HIGHLIGHTS: Fortis Research Institute In Gurugram Starts Sputnik-V Trial Run For Public
Coronavirus HIGHLIGHTS: In Tamil Nadu, a total of nine Delta Plus variant cases have been reported, said the State Health Minister Ma Subramanian. The third wave of Covid 19 won't be as severe as the second wave reveals ICMR study.
LIVE
Background
Coronavirus HIGHLIGHTS, Sunday, June 27: A new coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will be available soon for those between 12-18 years of age, the central government said in an affidavit to the Supreme Court on Saturday.
Filed in response to the Supreme Court's pointed questions about the vaccination drive that followed a dramatic overhaul in its policy earlier this month, the centre also briefed the court about its plans to vaccinate all adults in the country by the end of the year.
It said that 186.6 crore doses are needed to vaccinate people above 18 years who number 93-94 crore.
The Delta variant of COVID-19, identified in at least 85 countries and first detected in India, is likely responsible for the exponentially rising daily number of virus cases in South Africa's economic hub, Gauteng province.
Russia has reported its highest daily COVID-19 death toll of the year as the country grapples with a sharp spike in infections that has brought new restrictions in some regions. The national coronavirus task force said Saturday that 619 people died over the past day, the most since December 24. There were 21,665 new infection cases, nearly 1,300 more than on the previous day and more than double the 9,500 reported on June 1.
Fortis Memorial Research Institute starts Sputnik-V trial run
Fortis Memorial Research Institute in Gurugram has started trial run of Russian jab SputnikV for the general public.
Haryana records 17 more fatalities, 115 fresh cases
Haryana on Sunday reported 17 more Covid-related deaths, which took the cumulative toll to 9,385, while 115 fresh cases pushed the tally to 7,68,378 in the state, according to the health department's daily bulletin. The latest deaths include two each from Gurgaon and Hisar districts, it said.
Of the fresh cases, Palwal reported 20 cases while 16 cases were from Gurgaon, the bulletin said. The active cases in the state stand at 1,685. The total recoveries so far are 7,57,308, and the recovery rate is 98.56 per cent, it said. The cumulative positivity rate is 7.74 per cent, the bulletin said.
100 booked for violating Covid guidelines in J-K's Samba
Police in Jammu and Kashmir's Samba district booked 100 people on Sunday for violation of COVID-19 guidelines and imposed fines worth around Rs 50,000 on them.
The violators included shopkeepers who were fined for not wearing face masks or not maintaining social distancing on their premises, a police spokesperson said.
He added that police personnel distributed face masks among the public all day to infuse a sense of responsibility to contain the spread of the coronavirus.
While 80 people were fined for not wearing masks, 13 were penalised for not maintaining social distance and seven for spitting in public places, the spokesman said.
In nearby Kathua district, 43 people were penalised for not following Covid-appropriate behaviour and fines worth Rs 19,500 imposed on Sunday, a police official said.
Mumbai reports 746 new COVID-19 cases, 13 deaths
Serum Institute of India produces over 10 crore doses of Covishield in June
Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its COVID-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection.
India's COVID-19 inoculation drive has picked up pace under the new phase of universalisation of COVID-19 vaccination that commenced on June 21 with around 69 lakh vaccine doses being administered on an average daily in the last six days.
The immunisation data published at 7 am on Sunday showed that India administered 64.25 lakh vaccine doses in a day, taking the cumulative number of jabs given so far under the nationwide inoculation drive to 32.17 crore.
According to information provided to the Drugs Controller General of India (DCGI) by the Pune-based Serum Institute of India, it has sent 45 batches of Covishield, amounting to 10.80 crore doses, to the Central Drugs Laboratory, Kasauli for release in June so far.
The firm's Director at Government and Regulatory Affairs, Prakash Kumar Singh, had in May communicated to Union Home Minister Amit Shah that Covishield production would be ramped up to 10 crore doses in June.
"We are committed to enhancing the production capacity of our Covishield vaccine and have been working round-the-clock in spite of various challenges being faced by us because of COVID-19 pandemic.
"We are pleased to inform that in the month of June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to our country as compared to our present production capacity of 6.5 crore doses in May," Singh had said in a communication to Shah.
Top Headlines
Trending News
and tablets
